Gilead's Compassionate Use Data Promising, But Imminent COVID-19 Treatment Shift Unlikely

 
• By Sarah Karlin-Smith
  
Gilead sign at headquarters in Silicon Valley. Gilead Sciences, Inc. is an American biotechnology company that researches, develops and commercializes drugs - Foster City, California, USA - 2020
Gilead's experimental antiviral remdesivir may have helped COVID-19 patients, compassionate use data shows • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D